The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase III study of taselisib (GDC-0032) + fulvestrant (FULV) v FULV in patients (pts) with estrogen receptor (ER)-positive, PIK3CA-mutant (MUT), locally advanced or metastatic breast cancer (MBC): Primary analysis from SANDPIPER.
 
Jose Baselga
No Relationships to Disclose
 
Susan Faye Dent
No Relationships to Disclose
 
Javier Cortés
No Relationships to Disclose
 
Young-Hyuck Im
No Relationships to Disclose
 
Véronique Diéras
No Relationships to Disclose
 
Nadia Harbeck
No Relationships to Disclose
 
Ian E. Krop
No Relationships to Disclose
 
Sunil Verma
No Relationships to Disclose
 
Timothy R. Wilson
No Relationships to Disclose
 
Huan Jin
No Relationships to Disclose
 
Lijia Wang
No Relationships to Disclose
 
Frauke Schimmoller
No Relationships to Disclose
 
Jerry Y. Hsu
No Relationships to Disclose
 
Jing He
No Relationships to Disclose
 
Michelino DeLaurentiis
No Relationships to Disclose
 
Pamela Drullinsky
No Relationships to Disclose
 
William Jacot
No Relationships to Disclose